Pacira BioSciences (PCRX) News Today $24.87 -0.55 (-2.16%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$24.88 +0.00 (+0.02%) As of 06/10/2025 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PCRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Bridge City Capital LLC Reduces Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)Bridge City Capital LLC reduced its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 24.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 172,146 shares of the company's stock after sellinJune 9 at 9:16 AM | marketbeat.comWall Street Zen Upgrades Pacira BioSciences (NASDAQ:PCRX) to BuyJune 9 at 2:33 AM | americanbankingnews.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 21,781 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 26.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutionJune 8 at 3:40 AM | marketbeat.comLauren Riker Sells 5,578 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) StockJune 7, 2025 | insidertrades.comPacira BioSciences (NASDAQ:PCRX) Upgraded at Wall Street ZenWall Street Zen raised shares of Pacira BioSciences from a "hold" rating to a "buy" rating in a research note on Friday.June 7, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) SVP Sells $146,199.38 in StockPacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) SVP Lauren Riker sold 5,578 shares of the company's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $26.21, for a total transaction of $146,199.38. Following the completion of the transaction, the senior vice president now owns 59,564 shares in the company, valued at approximately $1,561,172.44. This represents a 8.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.June 6, 2025 | marketbeat.comPacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 5, 2025 | globenewswire.comWellington Management Group LLP Has $8.86 Million Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Wellington Management Group LLP raised its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 3.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 470,191 shares of the company's stock after acquiring an additional 15,542 shares during thJune 3, 2025 | marketbeat.comPublic Employees Retirement System of Ohio Has $1.72 Million Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)Public Employees Retirement System of Ohio lifted its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 21,458.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 91,192 shares of the company's stoJune 3, 2025 | marketbeat.comTwo Sigma Advisers LP Purchases New Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Two Sigma Advisers LP purchased a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 42,300 shares of the company's stock, valued at approxiJune 3, 2025 | marketbeat.comZacks Research Has Optimistic Outlook of PCRX Q3 EarningsJune 3, 2025 | americanbankingnews.comTwo Sigma Investments LP Purchases 45,222 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Two Sigma Investments LP grew its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 65.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 114,682 shares of the company's stock after acquiring an additional 45,222 shares during the period. TwJune 2, 2025 | marketbeat.comQ3 EPS Estimate for Pacira BioSciences Raised by AnalystPacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) - Analysts at Zacks Research increased their Q3 2025 EPS estimates for Pacira BioSciences in a note issued to investors on Thursday, May 29th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share ofJune 2, 2025 | marketbeat.comSquarepoint Ops LLC Boosts Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Squarepoint Ops LLC grew its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 72.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 60,836 shares of the company's stock after buying an additional 25,505 shares during theJune 1, 2025 | marketbeat.comVoloridge Investment Management LLC Increases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)Voloridge Investment Management LLC increased its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 129.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 116,149 shares of the company'May 29, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Nuveen Asset Management LLCNuveen Asset Management LLC grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 109.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 625,917 shares of the company's stock after purchasing an additional 327,May 29, 2025 | marketbeat.comAmeriprise Financial Inc. Acquires 194,597 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Ameriprise Financial Inc. boosted its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 150.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 324,261 shares of the company's stock after purchasing aMay 26, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Recommendation of "Hold" from BrokeragesShares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) have received an average rating of "Hold" from the nine brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and four hMay 26, 2025 | marketbeat.comPacira at RBC Conference: Strategic Growth and Gene Therapy FocusMay 23, 2025 | uk.investing.comPacira BioSciences (NASDAQ:PCRX) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 57%May 22, 2025 | finance.yahoo.comGraham Capital Management L.P. Sells 61,645 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Graham Capital Management L.P. lowered its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 83.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,268 shares of the company's stock after sellingMay 21, 2025 | marketbeat.com1,075,673 Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX) Purchased by Point72 Asset Management L.P.Point72 Asset Management L.P. bought a new position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,075,673 shares of thMay 20, 2025 | marketbeat.comGotham Asset Management LLC Cuts Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Gotham Asset Management LLC cut its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 28.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 64,948 shares of the company's stock after selling 25,965 shares during the period.May 20, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Comerica BankComerica Bank reduced its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 69.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,134 shares of the company's stock after selling 37,055 shares dMay 19, 2025 | marketbeat.comNorthern Trust Corp Buys 145,205 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Northern Trust Corp increased its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 30.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 616,891 shares of the company's stock after acquiring an additional 145,May 19, 2025 | marketbeat.comNumerai GP LLC Buys Shares of 15,724 Pacira BioSciences, Inc. (NASDAQ:PCRX)Numerai GP LLC bought a new position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 15,724 shares of the company's stock, valued at approximately $296,000. Several other institutional investors havMay 18, 2025 | marketbeat.comBNP Paribas Financial Markets Sells 173,956 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)BNP Paribas Financial Markets cut its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 44.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 221,739 shares of the company's stock after selling 173,May 17, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Takes $8.56 Million Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Jacobs Levy Equity Management Inc. purchased a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 454,261 shares of the company's stock, valMay 16, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Voya Investment Management LLCVoya Investment Management LLC lowered its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 68.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,948 shares of the company's stock after sellingMay 15, 2025 | marketbeat.comRaymond James Financial Inc. Invests $190,000 in Pacira BioSciences, Inc. (NASDAQ:PCRX)Raymond James Financial Inc. bought a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 10,099 shares of the company's stock, vMay 15, 2025 | marketbeat.comPacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare ConferencesMay 14, 2025 | globenewswire.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Algert Global LLCAlgert Global LLC decreased its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 54.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 26,625 shares of the company's stock after selling 32,223 shares during the period. AlgerMay 13, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC lowered its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 66.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 186,952 shares of the company's stock after selling 367,435 shares duMay 12, 2025 | marketbeat.comBokf Na Buys New Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)Bokf Na purchased a new position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,212 shares of the company's stock, valued aMay 12, 2025 | marketbeat.comBalyasny Asset Management L.P. Makes New Investment in Pacira BioSciences, Inc. (NASDAQ:PCRX)Balyasny Asset Management L.P. purchased a new stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 434,206 shares of the company's stock,May 12, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Given New $30.00 Price Target at Needham & Company LLCNeedham & Company LLC reduced their price objective on Pacira BioSciences from $32.00 to $30.00 and set a "buy" rating for the company in a research report on Friday.May 11, 2025 | marketbeat.comTruist Financial Sticks to Its Hold Rating for Pacira Pharmaceuticals (PCRX)May 11, 2025 | theglobeandmail.com33,813 Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX) Bought by Brevan Howard Capital Management LPBrevan Howard Capital Management LP bought a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 33,813 shares of tMay 11, 2025 | marketbeat.comAxa S.A. Buys Shares of 89,482 Pacira BioSciences, Inc. (NASDAQ:PCRX)Axa S.A. purchased a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 89,482 shares of the company's stock, valued at approximately $1,686,0May 11, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by AQR Capital Management LLCAQR Capital Management LLC reduced its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 47.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 288,499 shares of the company's stock after selling 257,709May 11, 2025 | marketbeat.comTudor Investment Corp ET AL Purchases New Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX)Tudor Investment Corp ET AL acquired a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 22,649 shares of the company's stock, valued at approximately $42May 11, 2025 | marketbeat.comEarnings call transcript: Pacira Q1 2025 shows revenue miss, stock dipsMay 10, 2025 | uk.investing.comPacira outlines growth potential with $725M-$765M 2025 revenue target and EXPAREL expansion to 2039May 10, 2025 | msn.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Caption Management LLCCaption Management LLC lowered its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 59.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,844 shares of the company's stock afteMay 9, 2025 | marketbeat.comBridgeway Capital Management LLC Purchases 11,149 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Bridgeway Capital Management LLC boosted its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 3.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 358,785 shares of the company's stock after buyingMay 9, 2025 | marketbeat.comPacira BioSciences, Inc. (PCRX) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comPacira BioSciences, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 8, 2025 | seekingalpha.comPacira BioSciences Reports First Quarter 2025 Financial ResultsMay 8, 2025 | globenewswire.comDimensional Fund Advisors LP Decreases Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Dimensional Fund Advisors LP trimmed its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 2.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,832,216 shares of the company's stock after sellingMay 7, 2025 | marketbeat.comPacira BioSciences soars 52% following InvestingPro’s October Fair Value alertMay 5, 2025 | investing.com Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address PCRX Media Mentions By Week PCRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCRX News Sentiment▼0.920.71▲Average Medical News Sentiment PCRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCRX Articles This Week▼1010▲PCRX Articles Average Week Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Perrigo News Today Supernus Pharmaceuticals News Today Nektar Therapeutics News Today Omeros News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCRX) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
